Aviva. Taking care of what's important

Forward Thinking

Log-in:
(Forgot your password?)

The views and statements expressed in this forum do not necessarily reflect those of Aviva or The Economist; nor is anyone authorised to represent the views of Aviva or The Economist in this forum.

Local time  

Aviva World - opens in a new browser

Future of the Human Body


Doctors are being asked increasingly by healthy people to prescribe Ritalin and other “cognitive enhancers” that boost their mental abilities—believing such drugs will give them an edge in the office or classroom. Treating genuine sufferers of Alzheimer’s or attention-deficit disorder this way is one thing, but no-one knows how such drugs affect the brain’s delicate chemistry over the long term. Will social pressures force the rest of us to medicate ourselves to compete and appear “normal”?

Read the full article, click here

Listen to the podcast: Wired for action


Approx. 12 mins

Dr Colin Blakemore, head of the UK's Medical Research Council, discusses the social and medical implications of normal people taking cognitive-enhancing drugs, including even caffeine.

Listen to the podcast, click here.

To save the MP3 file, right-click the link and use the "Save Link As" option.

All Categories > Forward Thinking > Future of Human Body > “Off label” uses for medications
Total Posts: 2 - Pages (1): [1]
Author: Moderator
Posted: Oct 02 2006 - 01:13 PM
Subject: “Off label” uses for medications
With the drug industry’s rush to develop new Alzheimer’s drugs, are we in for a flood of “off label” uses for such medications?
Author: bickertway
Posted: Oct 09 2006 - 10:40 AM
Subject: re: “Off label” uses for medications
I think that its very dangerous to use drugs for purposes other than what they were specifically designed to do. Its been reported that kids without Alzheimers are being fed these drugs to ensure they learn quicker which I must admit is appalling but I agree that we have no idea what the long term effects of these drugs will have.

Total Posts: 2 - Pages (1): [1]

Top of page

© AVIVA plc 2005-2006